A new study led by Lund University in Sweden has solved a years-old mystery: which patients with aggressive breast cancer are helped by a targeted cancer treatment that had been under development but was shelved.
Masimo prevails against Apple in USITC patent investigation
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The U.S. International Trade Commission